the benefits of glp 1 drugs beyond obesity expanding role GLP-1 receptor agonists: a narrative review of current evidence and future directions GLP-1R agonists: Full of hope,

The expression vectors for the FIX albumin fusion variants were kindly provided by Alessio Branchini (University of Ferrara, Italy) 9

7,33 Our analysis revealed that papilledema was significantly improved in the GLP-1 agonist group compared to the usual care group

3335 Autoimmunity against DPP4 has also been observed in RA patients, suggesting a potential role for DPP4 in the autoimmune response associated with the disease

Nausea is the most common side effect reported with GLP-1 RAs in up to 50% of patients [61,62]

We calculated this by taking the product of the weights calculated from the conditional probabilities of treatment discontinuation or switching, administrative censoring (end of study period/end of registration with practice), and death by using the covariates listed above